Siman Robert, Zhang Chen, Roberts Victoria L, Pitts-Kiefer Alex, Neumar Robert W
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084, USA.
J Cereb Blood Flow Metab. 2005 Nov;25(11):1433-44. doi: 10.1038/sj.jcbfm.9600138.
Previously, we identified proteins released from degenerating cultured cortical neurons as novel cerebrospinal fluid (CSF) markers for acute brain injury in the rat. Here, we investigate relationships between CSF changes in these novel markers and the severity of acute ischemic brain injury. Rats underwent sham surgery or 3,6,8, or 10 mins of transient global forebrain ischemia. At 48 h after insult, CSF levels of 14-3-3beta, 14-3-3zeta, and calpain cleavage products of alpha-spectrin and tau were quantified. Regional acute neurodegeneration was assessed by Fluoro-Jade and silver impregnation staining, and confirmed by immunohistochemical detection of the activation of calpain and caspase, cysteine proteases involved in neurodegenerative signaling. Ischemic neurodegeneration and activation of at least one cysteine protease were observed in the hippocampal CA1 sector, dentate hilus, caudate nucleus, parietal cortex, thalamus, and inferior colliculus. As expected, the total number of degenerating cells increased as a function of ischemia duration. Cerebrospinal fluid levels of the four marker proteins increased markedly after ischemia, and rose in proportion with its duration. Irrespective of the length of ischemia, CSF levels of the neuron-enriched proteins 14-3-3beta and calpain-cleaved tau correlated significantly with the magnitude of acute ischemic neurodegeneration. Additionally, CSF levels of the two proteins correlated with one another. These results show that certain proteins released from degenerating neurons are CSF markers for brain injury in the rat whose levels reflect the severity of acute ischemic neurodegeneration. Measurement of 14-3-3beta and calpain-cleaved tau may be useful for the minimally invasive diagnosis, prognosis, and therapeutic evaluation of acute brain damage.
此前,我们鉴定出从退化的培养皮层神经元释放的蛋白质,作为大鼠急性脑损伤的新型脑脊液(CSF)标志物。在此,我们研究这些新型标志物的脑脊液变化与急性缺血性脑损伤严重程度之间的关系。大鼠接受假手术或3、6、8或10分钟的短暂全脑缺血。在损伤后48小时,对14-3-3β、14-3-3ζ以及α-血影蛋白和tau的钙蛋白酶裂解产物的脑脊液水平进行定量。通过Fluoro-Jade和银浸染染色评估局部急性神经变性,并通过免疫组织化学检测参与神经变性信号传导的半胱氨酸蛋白酶钙蛋白酶和半胱天冬酶的激活来确认。在海马CA1区、齿状回门、尾状核、顶叶皮层、丘脑和下丘脑中观察到缺血性神经变性和至少一种半胱氨酸蛋白酶的激活。正如预期的那样,退化细胞的总数随着缺血持续时间的增加而增加。缺血后脑脊液中四种标志物蛋白的水平显著升高,并与其持续时间成比例上升。无论缺血时间长短,富含神经元的蛋白14-3-3β和钙蛋白酶裂解的tau的脑脊液水平与急性缺血性神经变性的程度显著相关。此外,这两种蛋白的脑脊液水平相互关联。这些结果表明,从退化神经元释放的某些蛋白质是大鼠脑损伤的脑脊液标志物,其水平反映了急性缺血性神经变性的严重程度。检测14-3-3β和钙蛋白酶裂解的tau可能有助于急性脑损伤的微创诊断、预后评估和治疗评估。